FDA Approved: RABEPRAZOLE SODIUM — Supplemental Application (Advagen Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for Rabeprazole sodium by Advagen Pharma Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duodenal Ulcer
• Erosive Esophagitis
• Gastric Ulcer
• Gastroesophageal Reflux Disease
• Helicobacter Pylori Infection
• Non-erosive Reflux Disease

Drugs mentioned

• Rabeprazole sodium (rabeprazole)

Snippet

SUPPL AP for RABEPRAZOLE SODIUM (RABEPRAZOLE SODIUM)